401k Plan data: PHARMSCRIPT LLC 401K PLAN plan

PHARMSCRIPT LLC 401K PLAN 401k Plan overview

Plan Name	PHARMSCRIPT LLC 401K PLAN
Plan identification number	001

PHARMSCRIPT LLC 401K PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

PHARMSCRIPT LLC has sponsored the creation of one or more 401k plans.

Company Name: PHARMSCRIPT LLC

Employer identification number (EIN): 264028903

NAIC Classification: 446110
NAIC Description: Pharmacies and Drug Stores

Form 5500 Filing Information

Submission information for form 5500 for 401k plan PHARMSCRIPT LLC 401K PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2016-01-01 CHANA HOFF
001 2015-01-01 CHANA HOFF
001 2014-01-01 CHANA HOFF
001 2013-01-01 CHANA HOFF
001 2012-01-01 CHANA HOFF 2013-08-25
001 2011-01-01 CHANA HOFF 2012-07-02
001 2010-01-01 CHANA HOFF 2011-05-26

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed
001	2016-01-01	CHANA HOFF
001	2015-01-01	CHANA HOFF
001	2014-01-01	CHANA HOFF
001	2013-01-01	CHANA HOFF
001	2012-01-01	CHANA HOFF	2013-08-25
001	2011-01-01	CHANA HOFF	2012-07-02
001	2010-01-01	CHANA HOFF	2011-05-26

Plan Statistics for PHARMSCRIPT LLC 401K PLAN

401k plan membership statisitcs for PHARMSCRIPT LLC 401K PLAN

Measure Date Value
2016: PHARMSCRIPT LLC 401K PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 444
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 434
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 16
Total of all active and inactive participants 2016-01-01 450
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 450
Number of participants with account balances 2016-01-01 137
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 18
2015: PHARMSCRIPT LLC 401K PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 304
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 376
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 21
Total of all active and inactive participants 2015-01-01 397
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 397
Number of participants with account balances 2015-01-01 122
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 9
2014: PHARMSCRIPT LLC 401K PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 228
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 264
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 12
Total of all active and inactive participants 2014-01-01 276
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 276
Number of participants with account balances 2014-01-01 91
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 6
2013: PHARMSCRIPT LLC 401K PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 163
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 192
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 6
Total of all active and inactive participants 2013-01-01 198
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 198
Number of participants with account balances 2013-01-01 65
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 5

Measure	Date	Value
2016: PHARMSCRIPT LLC 401K PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	444
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	434
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	16
Total of all active and inactive participants	2016-01-01	450
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	450
Number of participants with account balances	2016-01-01	137
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	18
2015: PHARMSCRIPT LLC 401K PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	304
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	376
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	21
Total of all active and inactive participants	2015-01-01	397
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	397
Number of participants with account balances	2015-01-01	122
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	9
2014: PHARMSCRIPT LLC 401K PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	228
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	264
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	12
Total of all active and inactive participants	2014-01-01	276
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	276
Number of participants with account balances	2014-01-01	91
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	6
2013: PHARMSCRIPT LLC 401K PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	163
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	192
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	6
Total of all active and inactive participants	2013-01-01	198
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	198
Number of participants with account balances	2013-01-01	65
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	5

Financial Data on PHARMSCRIPT LLC 401K PLAN

Measure	Date	Value
2016 : PHARMSCRIPT LLC 401K PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total transfer of assets to this plan	2016-12-31	$342,889
Total transfer of assets from this plan	2016-12-31	$4,273
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$607,301
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$75,040
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$54,408
Expenses. Certain deemed distributions of participant loans	2016-12-31	$417
Value of total corrective distributions	2016-12-31	$4,791
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$545,343
Value of total assets at end of year	2016-12-31	$1,751,178
Value of total assets at beginning of year	2016-12-31	$880,301
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$15,424
Total interest from all sources	2016-12-31	$440
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$120,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$406,713
Participant contributions at end of year	2016-12-31	$25,334
Participant contributions at beginning of year	2016-12-31	$10,808
Participant contributions at end of year	2016-12-31	$3,291
Participant contributions at beginning of year	2016-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$840
Administrative expenses (other) incurred	2016-12-31	$165
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$532,261
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$1,751,178
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$880,301
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Investment advisory and management fees	2016-12-31	$5,529
Interest on participant loans	2016-12-31	$397
Value of interest in common/collective trusts at end of year	2016-12-31	$1,059,729
Value of interest in common/collective trusts at beginning of year	2016-12-31	$418,570
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2016-12-31	$517,937
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2016-12-31	$377,487
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2016-12-31	$377,487
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2016-12-31	$43
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$61,518
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$137,790
Employer contributions (assets) at end of year	2016-12-31	$144,887
Employer contributions (assets) at beginning of year	2016-12-31	$73,436
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$54,408
Contract administrator fees	2016-12-31	$9,730
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	FULLER LOWENBERG & CO., CPAS, P.C.
Accountancy firm EIN	2016-12-31	200066099
2015 : PHARMSCRIPT LLC 401K PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$320,473
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$181,517
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$143,947
Expenses. Certain deemed distributions of participant loans	2015-12-31	$451
Value of total corrective distributions	2015-12-31	$25,216
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$341,926
Value of total assets at end of year	2015-12-31	$880,301
Value of total assets at beginning of year	2015-12-31	$741,345
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$11,903
Total interest from all sources	2015-12-31	$444
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$80,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$268,490
Participant contributions at end of year	2015-12-31	$10,808
Participant contributions at beginning of year	2015-12-31	$8,273
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$138,956
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$880,301
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$741,345
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Investment advisory and management fees	2015-12-31	$4,117
Interest on participant loans	2015-12-31	$411
Value of interest in common/collective trusts at end of year	2015-12-31	$418,570
Value of interest in common/collective trusts at beginning of year	2015-12-31	$365,881
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2015-12-31	$377,487
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2015-12-31	$301,088
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2015-12-31	$301,088
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2015-12-31	$33
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-21,897
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$73,436
Employer contributions (assets) at end of year	2015-12-31	$73,436
Employer contributions (assets) at beginning of year	2015-12-31	$66,103
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$143,947
Contract administrator fees	2015-12-31	$7,786
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	LOEB & TROPER LLP
Accountancy firm EIN	2015-12-31	131517563
2014 : PHARMSCRIPT LLC 401K PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total transfer of assets from this plan	2014-12-31	$335
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$313,963
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$45,210
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$15,860
Value of total corrective distributions	2014-12-31	$20,542
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$307,147
Value of total assets at end of year	2014-12-31	$741,345
Value of total assets at beginning of year	2014-12-31	$472,927
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$8,808
Total interest from all sources	2014-12-31	$303
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$80,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$241,044
Participant contributions at end of year	2014-12-31	$8,273
Participant contributions at beginning of year	2014-12-31	$6,313
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$268,753
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$741,345
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$472,927
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Investment advisory and management fees	2014-12-31	$3,314
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$365,881
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$422,208
Interest on participant loans	2014-12-31	$280
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2014-12-31	$301,088
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2014-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2014-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2014-12-31	$23
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$6,513
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$66,103
Employer contributions (assets) at end of year	2014-12-31	$66,103
Employer contributions (assets) at beginning of year	2014-12-31	$44,406
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$15,860
Contract administrator fees	2014-12-31	$5,494
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	LOEB & TROPER LLP
Accountancy firm EIN	2014-12-31	131517563
2013 : PHARMSCRIPT LLC 401K PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total transfer of assets from this plan	2013-12-31	$18,197
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$258,604
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$32,204
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$13,335
Expenses. Certain deemed distributions of participant loans	2013-12-31	$800
Value of total corrective distributions	2013-12-31	$11,264
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$230,127
Value of total assets at end of year	2013-12-31	$472,927
Value of total assets at beginning of year	2013-12-31	$264,724
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$6,805
Total interest from all sources	2013-12-31	$192
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$30,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$169,045
Participant contributions at end of year	2013-12-31	$6,313
Participant contributions at beginning of year	2013-12-31	$2,540
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$16,676
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$226,400
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$472,927
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$264,724
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Investment advisory and management fees	2013-12-31	$1,870
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$422,208
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$233,420
Interest on participant loans	2013-12-31	$180
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2013-12-31	$12
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$28,285
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$44,406
Employer contributions (assets) at end of year	2013-12-31	$44,406
Employer contributions (assets) at beginning of year	2013-12-31	$28,764
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$13,335
Contract administrator fees	2013-12-31	$4,935
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	LOEB & TROPER LLP
Accountancy firm EIN	2013-12-31	131517563

Form 5500 Responses for PHARMSCRIPT LLC 401K PLAN

2016: PHARMSCRIPT LLC 401K PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: PHARMSCRIPT LLC 401K PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: PHARMSCRIPT LLC 401K PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: PHARMSCRIPT LLC 401K PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

UNITEDHEALTHCARE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 79413 )
Policy contract number	602389
Policy instance	1

Potentially related plans

PHARMSCRIPT LLC 401K PLAN [EIN = 812306672]

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	PHARMSCRIPT LLC
Employer identification number (EIN):	264028903
NAIC Classification:	446110
NAIC Description:	Pharmacies and Drug Stores